Overview

Dose Ranging Study of OTO-201 in AOMT

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Dose Ranging Study of OTO-201 in AOMT
Phase:
Phase 2
Details
Lead Sponsor:
Otonomy, Inc.
Treatments:
Ciprofloxacin